Screener
CorMedix CRMD Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOther.
The source filing: CorMedix’s 10-K, filed March 5, 2026.
- Filed
- Mar 5, 2026, 8:32 AM EST
- Fiscal year
- FY2025
- Accession
- 0001213900-26-023889
| Line item | December 31, 2025 | December 31, 2024 |
|---|---|---|
| Sales Return | 7,756 | 210 |
| Tax Credit | 3,385 | - |
| Inventory reserve | 256 | - |
| Other | 616 | 528 |
| Total gross deferred tax assets | 181,093 | 69,168 |
| Less valuation allowance | (113,330) | (69,168) |
| Total Deferred tax assets net of valuation allowance | $67,763 | - |
| Deferred tax liabilities |
Item 16. Form 10-K Summary
FAQ
- What is CorMedix's deferred tax assets and other non-current assets?
- CorMedix (CRMD) reported deferred tax assets and other non-current assets of $616K in Q4 2025.
- How has CorMedix's deferred tax assets and other non-current assets changed year-over-year?
- CorMedix's deferred tax assets and other non-current assets increased by 16.7% year-over-year, from $528K to $616K.
- What is the long-term trend for CorMedix's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), CorMedix's deferred tax assets and other non-current assets has grown at a 96.5% compound annual growth rate (CAGR), from $21K to $616K.
Ask your AI about CorMedix's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude